These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 16873245)
1. Relationships between hepatitis C virus replication and CXCL-8 production in vitro. Koo BC; McPoland P; Wagoner JP; Kane OJ; Lohmann V; Polyak SJ J Virol; 2006 Aug; 80(16):7885-93. PubMed ID: 16873245 [TBL] [Abstract][Full Text] [Related]
2. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells. Plumlee CR; Lazaro CA; Fausto N; Polyak SJ Virol J; 2005 Dec; 2():89. PubMed ID: 16324217 [TBL] [Abstract][Full Text] [Related]
3. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons. Jarczak D; Korf M; Beger C; Manns MP; Krüger M FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954 [TBL] [Abstract][Full Text] [Related]
4. Stability of CXCL-8 and related AU-rich mRNAs in the context of hepatitis C virus replication in vitro. Green J; Khabar KS; Koo BC; Williams BR; Polyak SJ J Infect Dis; 2006 Mar; 193(6):802-11. PubMed ID: 16479515 [TBL] [Abstract][Full Text] [Related]
5. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment. Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259 [TBL] [Abstract][Full Text] [Related]
6. Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1). Miyamoto M; Kato T; Date T; Mizokami M; Wakita T Intervirology; 2006; 49(1-2):37-43. PubMed ID: 16166787 [TBL] [Abstract][Full Text] [Related]
7. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo. Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867 [TBL] [Abstract][Full Text] [Related]
8. [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon]. Jia YT; Wei L; Jiang D; Cong X; Fei R Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2065-9. PubMed ID: 16313804 [TBL] [Abstract][Full Text] [Related]
9. [Antiviral activities of ISG20 against hepatitis C virus]. Xu H; Lei Y; Zhong S; Peng FY; Zhou Z; Li K; Ren H Zhonghua Gan Zang Bing Za Zhi; 2013 Jan; 21(1):33-7. PubMed ID: 23663760 [TBL] [Abstract][Full Text] [Related]
10. Persistent replication of hepatitis C virus replicons expressing the beta-lactamase reporter in subpopulations of highly permissive Huh7 cells. Murray EM; Grobler JA; Markel EJ; Pagnoni MF; Paonessa G; Simon AJ; Flores OA J Virol; 2003 Mar; 77(5):2928-35. PubMed ID: 12584317 [TBL] [Abstract][Full Text] [Related]
12. MCPIP1 suppresses hepatitis C virus replication and negatively regulates virus-induced proinflammatory cytokine responses. Lin RJ; Chu JS; Chien HL; Tseng CH; Ko PC; Mei YY; Tang WC; Kao YT; Cheng HY; Liang YC; Lin SY J Immunol; 2014 Oct; 193(8):4159-68. PubMed ID: 25225661 [TBL] [Abstract][Full Text] [Related]
13. 2',5'-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro. Ishibashi M; Wakita T; Esumi M Biochem Biophys Res Commun; 2010 Feb; 392(3):397-402. PubMed ID: 20074559 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of hepatitis C virus replication by single-stranded RNA structural mimics. Smolic R; Smolic M; Andorfer JH; Wu CH; Smith RM; Wu GY World J Gastroenterol; 2010 May; 16(17):2100-8. PubMed ID: 20440850 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors. Korf M; Jarczak D; Beger C; Manns MP; Krüger M J Hepatol; 2005 Aug; 43(2):225-34. PubMed ID: 15964661 [TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha and ribavirin resistance of Huh7 cells transfected with HCV subgenomic replicon. Aus dem Siepen M; Oniangue-Ndza C; Wiese M; Ross S; Roggendorf M; Viazov S Virus Res; 2007 Apr; 125(1):109-13. PubMed ID: 17254660 [TBL] [Abstract][Full Text] [Related]
17. Novel hepatitis C virus reporter replicon cell lines enable efficient antiviral screening against genotype 1a. Robinson M; Yang H; Sun SC; Peng B; Tian Y; Pagratis N; Greenstein AE; Delaney WE Antimicrob Agents Chemother; 2010 Aug; 54(8):3099-106. PubMed ID: 20516274 [TBL] [Abstract][Full Text] [Related]
19. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system. Kato T; Date T; Miyamoto M; Sugiyama M; Tanaka Y; Orito E; Ohno T; Sugihara K; Hasegawa I; Fujiwara K; Ito K; Ozasa A; Mizokami M; Wakita T J Clin Microbiol; 2005 Nov; 43(11):5679-84. PubMed ID: 16272504 [TBL] [Abstract][Full Text] [Related]
20. Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication. Coto-Llerena M; Koutsoudakis G; Boix L; López-Oliva JM; Caro-Pérez N; Fernández-Carrillo C; González P; Gastaminza P; Bruix J; Forns X; Pérez-Del-Pulgar S Virus Res; 2017 Aug; 240():35-46. PubMed ID: 28751105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]